Multiple myeloma: open trials in New Zealand

• NCT05519085

  A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

  Trial Treatment · Phase 3 · Celgene

  Auckland · Auckland · Dunedin · Tauranga

  Registry updated 2026-10-30

• NCT05623020

  A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

  Trial Treatment · Phase 3 · Pfizer

  North Shore Hospital, Auckland · Auckland City Hospital, Grafton · Waikato Hospital, Hamilton · Capital, Coast and Hutt Valley District - Wellington Regional Hospital, Newtown

  Registry updated 2026-10-27

• NCT05669989

  International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

  Trial Treatment · Phase 2 · Sanofi

  Auckland · Wellington

  Registry updated 2026-10-15

• NCT05020236

  A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

  Trial Treatment · Phase 3 · Pfizer

  Labtests Auckland Ltd., Auckland · North Shore Hospital, Auckland · Aotearoa Clinical Trials, Auckland · Waikato District Health Board, Waikato Hospital, Hamilton · TRG Imaging, Milford · Pacific Radiology, Newtown · Broadway Radiology, Palmerston North · Palmerston North Hospital, Roslyn · Pharmacy on Shakespeare, Takapuna · Capital, Coast and Hutt Valley District - Wellington Regional Hospital, Wellington

  Registry updated 2026-08-24

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error